Communication
RSC Advances
6A-Azido-6C-3-methoxypropylimidazolium-b-cyclodextrin
mesitylene sulfonate 5b (2.8 g, 83%)
1H NMR (500 MHz, DMSO-d6) d: 9.12 (s, 1H, ]CH2im), 7.78
(s, 1H, ]CH5im), 7.72 (s, 1H, ]CH4im), 7.37 (s, 2H, ]CH), 5.94–
5.64 (m, 14H, OH-2 and OH-3), 4.97–4.79 (m, 7H, H-1), 4.63–4.57
129.7 (Cm-OMess), 137.8 (C2im), 131.5 (C–N), 130.9 (C4im), 128.4
(C5im), 123.20 (CH–N), 102.9 (C1), 84.5 (C4), 73.2 (C2), 73.00
(CH2-OCH ), 71.9 (C3), 72.6 (C5), 68.1 (C50), 60.5 (C6), 60.80
3
(CH2-OH), 48.7 (CH2-im), 27.4 (CH2-CN), 22.6 (CH3-o-OMess), 19.8
(CH3-p-OMess); FT-IR (cmꢃ1, KBr): 3311 (O–H str), 2927 (C–H str),
1643 (C]C str), 1333(C–N stre), 1161 (N]N str), 1012 (C–O–C str).
(m, 5H, OH-6), 4.21 (m, 2H, –CH2-im), 3.87 (m, 2H, CH2-OCH ),
3
3.62–3.47 (m, 26H, H-5, H-3 and H-6), 3.33–3.30 (m, 14H, H-2
and H-4), 3.22 (s, 3H, –OCH3), 2.69 (m, 2H, CH2), 2.45 (s, 6H,
–CH3-o-OMess), 2.25 (s, 3H, –CH3-p-OMess); 13C NMR (125 MHz,
DMSO-d6) d: 142.1 (Cipso), 136.4 (Co-OMess), 135.9 (Cp-OMess),
129.8 (Cm-OMess), 128.4 (C2im), 127.3 (C4im), 126.4 (C5im), 102.7
6A-4-Hydroxyethyl-1,2,3-triazole-6C-methoxyalkylimidazolium-
b-cyclodextrin chloride 7
An aqueous solution of 6a (1.0 g, 0.66 mmol) or 6b (1.0 g, 0.65
mmol) was immersed into a column lled with Amberlite IRA-
900 ion-exchange resin for 12 h. The eluent was collected and
evaporated to afford the title product 7 as a white solid.
(C1), 82.9 (C4), 73.2 (C2), 72.9(CH2-OCH ), 72.69 (C3), 68.2 (C5),
3
60.6 (CH2-OH), 60.5 (C6), 58.4 (OCH3), 48.65 (CH2-im), 29.7 (CH2),
22.8 (CH3-o-OMess), 19.5 (CH3-p-OMess); FT-IR (cmꢃ1, KBr):
3300 (O–H str), 2917 (C–H str), 2102 (N^N str), 1668 (C]C str),
1387 (C–N str), 1143 (S]O str), 1013 (C–O–C str).
6A-4-Hydroxyethyl-1,2,3-triazole-6C-2-
methoxyethylimidazolium-b-cyclodextrin chloride 7a
(0.85 g, 94%)
1H NMR (500 MHz, DMSO-d6) d: 9.11 (s, 1H, ]CH2im), 7.93 (s,
1H, ]CH), 7.77 (s, 1H, ]CH5im), 7.71 (s, 1H, ]CH4im), 5.96–
5.69 (m, 14H, OH-2 and OH-3), 4.95–4.82 (m, 7H, H-1), 4.58–4.51
6A-4-Hydroxyethyl-1,2,3-triazole-6C-methoxyalkylimidazolium-
b-cyclodextrin mesitylene sulfonate 6
A mixture of 5 (5a, 1.45 g, 1.0 mmol; 5b, 1.48 g, 1.0 mmol),
cuprous iodide triphenylphosphine (60 mg, 0.1 mmol), 3-butyn-
1-ol (0.076 mL, 1.2 mmol) and DMF (15 mL) was reuxed at 90
ꢁC for 1 day. The reaction mixture was poured into acetone to
precipitate the crude product. The title product 6 was recrys-
tallized two times from water to afford a white solid.
(m, 5H, OH-6), 4.21 (m, 2H, –CH2-im), 3.95 (m, 2H, CH2-OCH ),
3
3.64–3.49 (m, 26H, H-5, H-3 and H-6), 3.35–3.29 (m, 14H, H-2
and H-4), 3.21 (s, 3H, –OCH3), 2.88 (t, 2H, CH2-OH), 2.74–2.72
(t, 2H, CH2); 13C NMR (125 MHz, DMSO-d6) d: 137.8 (C2im), 131.5
(C–N), 130.7 (C4im), 128.4 (C5im), 123.2 (]CH–N), 102.9 (C1),
83.6 (C4), 73.2 (C2), 73.0 (CH2-OCH ), 71.9 (C3), 72.5 (C5), 68.1
3
6A-4-Hydroxyethyl-1,2,3-triazole-6C-2-methoxyethylimidazolium-b-
cyclodextrin mesitylene sulfonate 6a (1.2 g, 79%)
1H NMR (500 MHz, DMSO-d6) d: 9.11 (s, 1H, ]CH2im), 7.93 (s, 1H,
]CH), 7.77 (s, 1H, ]CH5im), 7.71 (s, 1H, ]CH4im), 7.37 (s, 2H,
CHben), 6.02–5.74 (m, 14H, OH-2 and OH-3), 5.04–4.82 (m, 7H, H-
1), 4.58–4.51 (m, 5H, OH-6), 4.21 (m, 2H, –CH2-im), 3.95 (m, 2H,
(C50), 60.8 (CH2-OH) 60.52 (C6), 58.5 (OCH3), 48.6 (CH2-im), 29.7
(CH2-CN); IR (cmꢃ1, KBr): 3311 (O–H str), 2927 (C–H str), 1637
(C]C str), 1333 (C–N str), 1157 (N]N str), 1020 (C–O–C str).
6A-4-Hydroxyethyl-1,2,3-triazole-6C-3-methoxypropylimidazolium-
b-cyclodextrin chloride 7b (0.8 g, 90%)
CH2-OCH ), 3.64–3.49 (m, 26H, H-5, H-3 and H-6), 3.35–3.23 (m,
1H NMR (500 MHz, DMSO-d6) d: 9.12 (s, 1H, ]CH2im), 7.93 (s,
1H, ]CH), 7.78 (s, 1H, ]CH5im), 7.72 (s, 1H, ]CH4im), 5.94–
5.64 (m, 14H, OH-2 and OH-3), 4.97–4.79 (m, 7H, H-1), 4.63–4.57
3
14H, H-2 and H-4), 3.17 (s, 3H, –OCH3), 2.88 (t, 2H, CH2-OH), 2.74–
2.72 (t, 2H, CH2), 2.40 (s, 6H, –CH3-o-OMess), 2.25 (s, 3H,
–CH3-p-OMess); 13C NMR (125 MHz, DMSO-d6) d: 142.0 (Cipso),136.2
(Co-OMess), 136.0 (Cp-OMess), 129.7 (Cmeta-OMess), 137.8 (]C2im),
131.50 (C–N), 130.70 (]C4im), 128.44 (]C5im), 123.2 (CH–N),
(m, 5H, OH-6), 4.23 (m, 2H, –CH2-im), 3.97 (m, 2H, CH2-OCH ),
3
3.64–3.50 (m, 26H, H-5, H-3 and H-6), 3.36–3.30 (m, 14H, H-2
and H-4), 3.25 (s, 3H, –OCH3), 2.89 (t, 2H, CH2-OH), 2.74–2.72
(t, 2H, CH2), 2.65 (m, 2H, CH2); 13C NMR (125 MHz, DMSO-d6) d:
137.4 (C2im), 131.5 (C–N), 130.7 (C4im), 128.4 (C5im), 123.7
102.9 (C1), 83.9 (C4), 73.2 (C2), 73.0 (CH2-OCH ), 71.9 (C3), 72.6
3
(C5), 68.1 (C50), 60.5 (C6), 60.8 (CH2-OH), 58.5 (OCH3),
48.65 (CH2-im), 29.70 (CH2-CN), 22.3 (CH3-ortho-OMess), 20.4
(CH3-para-OMess); FT-IR (cmꢃ1, KBr): 3311 (O–H str), 2927 (C–H str),
1637 (C]C str), 1333 (C–N str), 1157 (N]N str),1020 (C–O–C str).
(]CH–N), 102.7 (C1), 83.9 (C4), 73.2 (C2), 73.1 (CH2-OCH ), 72.69
3
(C3), 68.2 (C5), 60.6 (CH2-OH), 60.5 (C6), 58.4 (OCH3), 48.65
(CH2-im), 30.6 (CH2-CN), 29.7 (CH2); FT-IR (cmꢃ1, KBr): 3311
(O–H str), 2927 (C–H str), 1643 (C]C str), 1333 (C–N str), 1161
(N]N str), 1012 (C–O–C str).
6A-4-Hydroxyethyl-1,2,3-triazole-6C-2-methoxyethylimidazolium-
b-cyclodextrin mesitylene sulfonate 6b (1.2 g, 75%)
1H NMR (500 MHz, DMSO-d6) d: 9.12 (s, 1H, ]CH2im), 7.94
(s, 1H, ]CH), 7.78 (s, 1H, ]CH5im), 7.72 (s, 1H, ]CH4im), 7.33
(s, 2H, CHben), 6.01–5.73 (m, 14H, OH-2 and OH-3), 5.16–4.98
(m, 7H, H-1), 4.58–4.51 (m, 5H, OH-6), 4.21 (m, 2H, –CH2-im),
References
1 T. J. Ward and K. D. Ward, Anal. Chem., 2010, 82, 4712.
2 S. E. Deeb, H. Watzig, D. A. EI-Hady, H. M. Albishri,
C. S. D. Griend and G. K. E. Scriba, Electrophoresis, 2014,
35, 170.
3 L. Suntornsuk, Anal. Bioanal. Chem., 2010, 398, 29–52.
4 M. Pioch, S. C. Bunz and C. Neusuß, Electrophoresis, 2012, 33,
3.95 (m, 2H, CH2-OCH ), 3.64–3.49 (m, 26H, H-5, H-3 and H-6),
3
3.35–3.23 (m, 14H, H-2 and H-4), 3.17 (s, 3H, –OCH3), 2.88
(t, 2H, CH2-OH), 2.74–2.72 (t, 2H, CH2), 2.65 (m, 2H, CH2), 2.36
(s, 6H, –CH3-o-OMess), 2.24 (s, 3H, –CH3-p-OMess); 13C NMR (125
MHz, DMSO-d6) d: 142.3 (Cipso), 136.2 (Co-OMess), 136.1 (Cp-OMess),
¨
1517.
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 54512–54516 | 54515